Copyright
©The Author(s) 2025.
World J Clin Oncol. Apr 24, 2025; 16(4): 104827
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104827
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104827
Table 3 Change in pain intensity using brief pain inventory score during the treatment period
Time point | BPI mean score | Standard deviation | Reduction from baseline | Percentage reduction (%) |
Baseline | 7.8 | 1.2 | - | - |
4 weeks | 5.2 | 1.4 | 2.6 | 33.3 |
8 weeks | 4.1 | 1.5 | 3.7 | 47.4 |
- Citation: Chakraborty P, Borgohain M. Evaluating pregabalin in cancer patients with chronic neuropathic pain and depression: an observational case series. World J Clin Oncol 2025; 16(4): 104827
- URL: https://www.wjgnet.com/2218-4333/full/v16/i4/104827.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i4.104827